Key Takeaways
- Jordanian air defenses intercepted eight Iranian missiles on Thursday after sirens blared across the kingdom, including the capital, Amman.
- The regional escalation follows U.S. airstrikes targeting Iranian infrastructure, which Tehran claims killed at least 14 people and wounded 78 others.
- BMO Capital Markets initiated coverage on GE HealthCare (GEHC) with a Market Perform rating and a $70 price target, citing near-term execution risks.
- Oil prices showed volatility as investors weighed whether the intensifying fire across the Gulf signals a full collapse of the regional ceasefire.
Iranian Missiles Breach Jordanian Airspace
Air raid sirens sounded across Jordan on Thursday morning as the country’s state news agency confirmed the detection of missiles launched from Iran. The Jordanian Armed Forces were placed on high alert, successfully intercepting eight missiles that breached the kingdom's airspace. No casualties or significant damages were immediately reported within Jordan, though the U.S. Embassy in Amman issued an urgent "shelter in place" warning for its citizens.
The missile launches appear to be part of a broader retaliatory campaign by Tehran following recent U.S. military strikes. Reports indicate that Iran also targeted U.S. military infrastructure in Kuwait, Qatar, and Bahrain using a combination of drones and ballistic missiles. This surge in hostilities comes as Iran prepares for the burial of late Supreme Leader Ayatollah Ali Khamenei, whose death in a February airstrike remains a central flashpoint in the ongoing conflict.
BMO Initiates "Show-Me" Stance on GE HealthCare
In the financial markets, BMO Capital Markets began its coverage of GE HealthCare (GEHC) with a neutral Market Perform rating. The firm established a $70.00 price target, suggesting a cautious outlook for the medical technology giant through the remainder of 2026. Analysts noted that while the company has a strong innovation pipeline, including products like Flyrcado, the financial benefits are likely "back-end loaded" toward 2027 and 2028.
The analyst report highlighted several "macro-driven" headwinds, including persistent weakness in the China market and the impact of inflationary costs, which the company previously estimated at $250 million for the year. GE HealthCare (GEHC) is currently navigating a transition period as it attempts to balance backlog conversion with rising material costs for critical components like memory chips. The stock is currently trading near its 52-week lows, with investors awaiting more consistent quarterly delivery.
Market Implications of Regional Instability
The escalating military exchanges between the United States and Iran have triggered renewed concern over global energy supplies. While oil prices initially spiked on news of the Jordanian interceptions, they later stabilized as traders assessed the tactical nature of the strikes. However, the threat to the Strait of Hormuz remains a critical variable for global markets, as any sustained disruption to energy shipments could force a re-evaluation of inflation forecasts for the second half of 2026.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.